CA2955569C — Prodrugs comprising an aminoalkyl glycine linker
Assigned to Ascendis Pharma AS · Expires 2023-02-14 · 3y expired
What this patent protects
The present invention relates to prodrugs of primary or secondary amine- or hydroxyl-compounds of formula (I): (see formula I) comprising biologically active moieties and phaimaceutically acceptable salts thereof, prodrug reagents, pharmaceutical compositions comprising said prod…
USPTO Abstract
The present invention relates to prodrugs of primary or secondary amine- or hydroxyl-compounds of formula (I): (see formula I) comprising biologically active moieties and phaimaceutically acceptable salts thereof, prodrug reagents, pharmaceutical compositions comprising said prodrugs and the use of said prodrugs.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.